Humate-p 1,200 unit VWF:rcos
Ended Awarded
- Contract number
- SPE2DB25FDJ12
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,542
Award facts
- Contract value 100% obligated
- $11,541.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,541.60 by the Defense Logistics Agency on April 25, 2025. The delivery order is for 1,200 units of HUMATE-P, a von Willebrand factor replacement product used in hemophilia and von Willebrand disease treatment. The contract carries no set-aside designation and requires ultimate completion by May 16, 2025, with performance occurring at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and extending through November 2026. The underlying IDC, managed through the Defense Logistics Agency's SPE2DB program, enables the federal government to procure a comprehensive range of pharmaceutical products including prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status and extensive portfolio of government contracts to provide direct pharmaceutical distribution to military health systems.
Quick answers
Who was awarded contract SPE2DB25FDJ12?
SPE2DB25FDJ12 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 25, 2025.
How much is contract SPE2DB25FDJ12 worth?
The government has obligated $11,542 on SPE2DB25FDJ12.
Is contract SPE2DB25FDJ12 an order under another contract?
Yes. SPE2DB25FDJ12 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ12 competed?
The extent of competition for SPE2DB25FDJ12 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award